Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Male Hypogonadism Global Clinical Trials Review, H1

Male Hypogonadism Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Male Hypogonadism Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Male Hypogonadism Global Clinical Trials Review, H1, 2015" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Male Hypogonadism 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Male Hypogonadism to Male Health Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Male Hypogonadism 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Male Hypogonadism Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Male Hypogonadism 33

Jun 15, 2015: Lipocine Announces Successful Completion of Food Effect Study for LPCN 1021, an Oral Testosterone Product Candidate 33

Jun 01, 2015: Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial for Fispemifene in Men With Symptomatic Secondary Hypogonadism 33

May 11, 2015: Lipocine Announces Presentation of Additional LPCN 1021 Clinical Data at American Urological Association Annual Meeting 34

Apr 30, 2015: Lipocine Announces Completion of LPCN 1021, Oral Testosterone, Phase 3 Clinical Trial 34

Apr 10, 2015: Lipocine Announces Presentation of Additional LPCN 1021 Clinical Data at American Society of Andrology 40th Annual Conference 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Repros Therapeutics Inc. 35

Clinical Trial Overview of Repros Therapeutics Inc. 35

Abbott Laboratories 37

Clinical Trial Overview of Abbott Laboratories 37

Bayer AG 39

Clinical Trial Overview of Bayer AG 39

Endo International Plc 41

Clinical Trial Overview of Endo International Plc 41

Eli Lilly and Company 42

Clinical Trial Overview of Eli Lilly and Company 42

Merck & Co., Inc. 43

Clinical Trial Overview of Merck & Co., Inc. 43

Ferring International Center S.A. 44

Clinical Trial Overview of Ferring International Center S.A. 44

GlaxoSmithKline Plc 45

Clinical Trial Overview of GlaxoSmithKline Plc 45

Clarus Therapeutics, Inc. 46

Clinical Trial Overview of Clarus Therapeutics, Inc. 46

Antares Pharma, Inc. 47

Clinical Trial Overview of Antares Pharma, Inc. 47

Clinical Trial Overview of Top Institutes / Government 48

Gulhane School of Medicine 48

Clinical Trial Overview of Gulhane School of Medicine 48

Massachusetts General Hospital 49

Clinical Trial Overview of Massachusetts General Hospital 49

U.S. Department of Veterans Affairs 50

Clinical Trial Overview of U.S. Department of Veterans Affairs 50

University of Washington 51

Clinical Trial Overview of University of Washington 51

Eunice Kennedy Shriver National Institute of Child Health and Human Development 52

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 52

Odense University Hospital 53

Clinical Trial Overview of Odense University Hospital 53

Rijnstate Hospital 54

Clinical Trial Overview of Rijnstate Hospital 54

Barnsley Hospital NHS Foundation Trust 55

Clinical Trial Overview of Barnsley Hospital NHS Foundation Trust 55

Boston University 56

Clinical Trial Overview of Boston University 56

National Institute on Aging 57

Clinical Trial Overview of National Institute on Aging 57

Five Key Clinical Profiles 58

Appendix 93

Abbreviations 93

Definitions 93

Research Methodology 94

Secondary Research 94

About GlobalData 95

Contact Us 95

Disclaimer 95

Source 96

List of Figures

Male Hypogonadism Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2015* 15

Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2015* 18

Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 94

List of Tables

Male Hypogonadism Therapeutics, Global, Clinical Trials by Region, 2015* 7

Male Hypogonadism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Male Hypogonadism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Male Hypogonadism Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Male Hypogonadism Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Male Hypogonadism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Male Hypogonadism Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Male Hypogonadism to Male Health Clinical Trials, G7 Countries (%), 2015* 15

Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Male Hypogonadism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Male Hypogonadism to Male Health Clinical Trials, E7 Countries (%), 2015* 18

Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Male Hypogonadism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Male Hypogonadism Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Male Hypogonadism Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Male Hypogonadism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Male Hypogonadism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Male Hypogonadism Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Male Hypogonadism Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Male Hypogonadism Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Male Hypogonadism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Male Hypogonadism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Male Hypogonadism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Male Hypogonadism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Male Hypogonadism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Repros Therapeutics Inc., 2015* 35

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 37

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International Plc, 2015* 41

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 42

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 43

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 44

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 45

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Clarus Therapeutics, Inc., 2015* 46

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Antares Pharma, Inc., 2015* 47

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Gulhane School of Medicine, 2015* 48

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 49

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 50

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 51

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 52

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2015* 53

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Rijnstate Hospital, 2015* 54

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnsley Hospital NHS Foundation Trust, 2015* 55

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2015* 56

Male Hypogonadism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2015* 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Repros Therapeutics Inc.

Abbott Laboratories

Bayer AG

Endo International Plc

Eli Lilly and Company

Merck & Co., Inc.

Ferring International Center S.A.

GlaxoSmithKline Plc

Clarus Therapeutics, Inc.

Antares Pharma, Inc.

Male Hypogonadism Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Male Hypogonadism, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com